MRVC announced Q1 results on May 8th. Revenues were $42.3 million up 9% from $38.9 million last year. GAAP net loss was $.58 a share, compared to a loss of $.59 per share last year. Non-GAAP loss was about $3.0 million compared to $4.4 million last year. Our valuation fell to $23.19 from $25.49 last quarter but up slightly from $23.19 last year. MRVC is trading at about 50% of our valuation. We will continue to HOLD as results showed continued losses, but sales continued to grow nicely,
CCUR announced Q3 2014 earnings after the close today. Revenues were $18.3 million, up 8% from last year and EPS was $.12 up 9% from last year. Net cash was $2.47 per share. Overall a nice quarter. Our valuation fell slightly to $15.01 from $15.10 last quarter. CCUR is trading at 56% of our valuation and cash is 30% of the market cap. If we were not up 98% on this, we would think about buying it here based on the valuation.
Bad week last week as we were down 4.4%, and are up 72.7% for 2014. The DOW was up .1% and NASDAQ was down 2.8%. For the year, the DOW is down 1.5% and NASDAQ is down .5%
No earnings last week.
Some of our stocks are just stupid cheap—compared to their net cash on hand per share divided by their stock price.
Check this list:
BLIN, DAEG, GRVY and CBEY can still be bought.
Last week we went 0 stocks up, 13 down and 1 unchanged. Since inception we are now 66 stocks up and 18 down for a 78.6% winning percentage (80% is our target win %).
Since our beginning, we have closed out the following positions: